Loading
Preparing the next Annolyse view.
Company archive
Each company archive keeps the publication history in release order, with the newest Annolyse briefing first.
Archive navigation
Company and sector routes have dedicated HTML, while the archive stays ordered by publication date.
Showing 1-9 of 9 published briefings.
Revenue fell 5.3% but the balance sheet restructuring done in FY25 transformed earnings; the question is whether second-half margins can hold.
Published 22 April 2026
Read briefingHeadline NPAT loss narrowed, but H2 EBITDA turned negative and operating cash flow collapsed 89% while net debt rose $7.5m.
Published 22 April 2026
Read briefingCash conversion fell to 37% of EBITDA and net debt rose, raising questions about whether the balance sheet can hold through a weak second half.
Published 22 April 2026
Read briefingRevenue fell 9.2% and the NPAT loss widened to $27.5m, with H2 EBITDA turning negative even as operating cash flow tripled.
Published 21 April 2026
Read briefingUnderlying earnings and cash conversion improved on a weaker revenue base, but the impairment signals a darker read on the New Zealand...
Published 21 April 2026
Read briefingUndisclosed significant items and a NZ$11.1m H2 NPAT swing overwhelmed an Australian Glass Group turnaround, while operating cash flow more than...
Published 21 April 2026
Read briefingOperating profit rebuilt to $5.6m and Australia swung into the black, yet PBT was flat and leverage rose to roughly 3.9x half-year EBITDA.
Published 21 April 2026
Read briefingTop line held up, but NZ segment EBIT more than halved, operating cash flow fell 56%, and inventory days jumped by roughly 13 days.
Published 21 April 2026
Read briefingCovid restrictions and shipping disruption hollowed out profitability while capex more than tripled, leaving FCF a fraction of the prior half.
Published 21 April 2026
Read briefingEmail updates
Get full analytical briefings by email as new coverage is published.